Opus Point Partners Management’s Loxo Oncology, Inc LOXO Stock Holding History

Opus Point Partners Management’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-6,210	Closed	-$870K	–	77
2018 Q4	$870K	Hold	6,210	–	–	1.91%	14
2018 Q3	$1.06M	Sell	6,210 -690	-10%	-$116K	2.53%	16
2018 Q2	$1.2M	Hold	6,900	–	–	2.6%	12
2018 Q1	$796K	Sell	6,900 -6,900	-50%	-$734K	1.56%	24
2017 Q4	$1.16M	Hold	13,800	–	–	1.01%	30
2017 Q3	$1.27M	Hold	13,800	–	–	1.14%	31
2017 Q2	$1.11M	Buy	+13,800	New	+$765K	1.01%	35
2016 Q2	–	Sell	-36,000	Closed	-$984K	–	58
2016 Q1	$984K	Sell	36,000 -24,000	-40%	-$502K	0.76%	31
2015 Q4	$1.71M	Buy	+60,000	New	+$1.61M	1.13%	27

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $5.27B AUM 41.17% 1-Year Est. Return

Opus Point Partners Management's LOXO Position: Q1 2019 in Review

Opus Point Partners Management sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 6,210 shares — an estimated $870K sold.

Opus Point Partners Management first reported a position in LOXO in Q4 2015 and held it in 9 quarters. The position peaked at $1.71M in Q4 2015. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Opus Point Partners Management reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Opus Point Partners Management sold 6,210 Loxo Oncology, Inc shares in Q1 2019, an estimated $870K.
Opus Point Partners Management first reported a position in Loxo Oncology, Inc in Q4 2015 and held it in 9 quarters.
Opus Point Partners Management's Loxo Oncology, Inc position peaked at $1.71M in Q4 2015.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Opus Point Partners Management's 13F filing for Q1 2019, filed 15 May 2019.